Spire Wealth Management Vaxxinity, Inc. Transaction History
Spire Wealth Management
- $3.01 Billion
- Q1 2024
A detailed history of Spire Wealth Management transactions in Vaxxinity, Inc. stock. As of the latest transaction made, Spire Wealth Management holds 8,969 shares of VAXX stock, worth $2,421. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,969
Previous 18,955
52.68%
Holding current value
$2,421
Previous $16,000
62.5%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding VAXX
# of Institutions
58Shares Held
12.2MCall Options Held
0Put Options Held
0-
Adage Capital Partners Gp, L.L.C. Boston, MA3MShares$810,0000.0% of portfolio
-
Black Rock Inc. New York, NY2.62MShares$708,2240.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.41MShares$651,1530.0% of portfolio
-
Geode Capital Management, LLC Boston, MA879KShares$237,2060.0% of portfolio
-
State Street Corp Boston, MA799KShares$215,8030.0% of portfolio
About Vaxxinity, Inc.
- Ticker VAXX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 112,150,000
- Market Cap $30.3M
- Description
- Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology and coronaviruses in the United States. The company engages in developing UB-311 that targets toxic forms of aggregated amyloid-b in the brain to fight Alzheimer's disease (AD) that is in phase 2 clinical trial; UB-312 that...